HJD treatment reduced the production of cytokines (TNF-α, IL-6, and IL-1β) and MPO in colon tissues, and enhanced ATT level in serum. The gene discussed is IL1B; the disease is spondyloepimetaphyseal dysplasia, Handigodu type.